Literature DB >> 14743661

Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases.

Raymond S Kandt1.   

Abstract

TSC and NF1 are the most common of the neurocutaneous diseases, and both are autosomal dominant with a high spontaneous mutation rate. For diagnosis, two features are necessary for each disease. Skin findings for each are especially helpful for diagnosis, as is neuroimaging in TSC. For NF1, neuroimaging is not yet reliable for diagnosis. In children, brain symptoms cause most of the morbidity in TSC, and nerve sheath and nervous system tumors as well as learning disabilities cause major morbidity in NF1. Renal disease becomes a serious problem for adults with TSC. The TSC1, TSC2, and NF1 genes function as tumor suppressor genes and have other functions that are being investigated. Blood tests for diagnosis have a high false-negative rate. Therapies for TSC and for NF1 are both medical and surgical.

Entities:  

Mesh:

Year:  2003        PMID: 14743661     DOI: 10.1016/s0733-8619(03)00004-5

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  8 in total

1.  Unilateral multiple facial angiofibromas: a case report with brief review of literature.

Authors:  Rameshwar Gutte; Uday Khopkar
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

Review 2.  The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.

Authors:  Sean P Delaney; Lisa M Julian; William L Stanford
Journal:  Front Cell Dev Biol       Date:  2014-11-25

3.  Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1.

Authors:  Shilpa Prabhakar; Pike See Cheah; Xuan Zhang; Max Zinter; Maria Gianatasio; Eloise Hudry; Roderick T Bronson; David J Kwiatkowski; Anat Stemmer-Rachamimov; Casey A Maguire; Miguel Sena-Esteves; Bakhos A Tannous; Xandra O Breakefield
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-16       Impact factor: 6.698

4.  Is polycystic kidney disease associated with malignancy in children?

Authors:  Brian D Friend; Kami Wolfe Schneider; Timothy Garrington; Laurel Truscott; Julian A Martinez-Agosto; Robert S Venick; Eileen Tsai Chambers; Patricia Weng; Douglas G Farmer; Vivian Y Chang; Noah Federman
Journal:  Mol Genet Genomic Med       Date:  2019-06-14       Impact factor: 2.183

5.  Neurofibromatosis 1: A family case series.

Authors:  Neha K Sethi; Charu Chadha; Sumit Goyal; Manpreet Kaur
Journal:  J Family Med Prim Care       Date:  2022-05-14

Review 6.  Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography.

Authors:  Barmak Abdolrahimzadeh; Domenica Carmen Piraino; Giorgio Albanese; Filippo Cruciani; Siavash Rahimi
Journal:  Clin Ophthalmol       Date:  2016-05-13

7.  Imaging Manifestations of a Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis.

Authors:  Joseph R Stein; Daniel A Reidman
Journal:  Case Rep Radiol       Date:  2016-01-31

8.  Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.

Authors:  Alexander A Goldberg; Kwang-Bo Joung; Asma Mansuri; Yujin Kang; Raquel Echavarria; Ljiljana Nikolajev; Yang Sun; Jane J Yu; Stephane A Laporte; Adel Schwertani; Arnold S Kristof
Journal:  Oncotarget       Date:  2016-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.